Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored.

Thomas BE, Thiruvengadam K, S R, Kadam D, Ovung S, Sivakumar S, Bala Yogendra Shivakumar SV, Paradkar M, Gupte N, Suryavanshi N, Dolla CK, Gupte AN, Kohli R, Pradhan N, Sivaramakrishnan GN, Gaikwad S, Kagal A, Dhanasekaran K, Deluca A, Golub JE, Mave V, Chandrasekaran P, Gupta A; CTRIUMPH-RePORT India Study.

PLoS One. 2019 Jul 31;14(7):e0220507. doi: 10.1371/journal.pone.0220507. eCollection 2019.

2.

70 years of TB Prevention: Efficacy, Effectiveness, Toxicity, Durability and Duration.

Salazar-Austin N, Dowdy DW, Chaisson RE, Golub JE.

Am J Epidemiol. 2019 Jul 31. pii: kwz172. doi: 10.1093/aje/kwz172. [Epub ahead of print]

PMID:
31364692
3.

Formative research for an mHealth program to improve the HIV care continuum in South Africa.

DiAndreth L, Krishnan N, Elf JL, Cox S, Tilchin C, Nthulana M, Jarrett B, Kronis N, Dupuis E, Motlhaoleng K, Chon S, Martinson N, Golub JE.

AIDS Care. 2019 Jul 12:1-5. doi: 10.1080/09540121.2019.1640850. [Epub ahead of print]

PMID:
31298566
4.

Diabetes mellitus and tuberculosis in Korean adults: impact on tuberculosis incidence, recurrence and mortality.

Golub JE, Mok Y, Hong S, Jung KJ, Jee SH, Samet JM.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):507-513. doi: 10.5588/ijtld.18.0103.

PMID:
31064631
5.

Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis.

Gupte AN, Selvaraju S, Paradkar M, Danasekaran K, Shivakumar SVBY, Thiruvengadam K, Dolla C, Shivaramakrishnan G, Pradhan N, Kohli R, John S, Raskar S, Jain D, Momin A, Subramanian B, Gaikwad A, Lokhande R, Suryavanshi N, Gupte N, Salvi S, Murali L, Checkley W, Golub JE, Bollinger R, Chandrasekaran P, Mave V, Gupta A.

Int J Tuberc Lung Dis. 2019 Apr 1;23(4):450-457. doi: 10.5588/ijtld.18.0551.

PMID:
31064624
6.

Cost-effectiveness of universal isoniazid preventive therapy among HIV-infected pregnant women in South Africa.

Kim HY, Hanrahan CF, Martinson N, Golub JE, Dowdy DW.

Int J Tuberc Lung Dis. 2018 Dec 1;22(12):1435-1442. doi: 10.5588/ijtld.18.0370.

7.

The association of household fine particulate matter and kerosene with tuberculosis in women and children in Pune, India.

Elf JL, Kinikar A, Khadse S, Mave V, Suryavanshi N, Gupte N, Kulkarni V, Patekar S, Raichur P, Paradkar M, Kulkarni V, Pradhan N, Breysse PN, Gupta A, Golub JE.

Occup Environ Med. 2019 Jan;76(1):40-47. doi: 10.1136/oemed-2018-105122. Epub 2018 Sep 7.

PMID:
30194271
8.

COach2Quit: a pilot randomized controlled trial of a personal carbon monoxide monitor for smoking cessation.

Krishnan N, Elf JL, Chon S, Golub JE.

Nicotine Tob Res. 2018 Aug 29. doi: 10.1093/ntr/nty182. [Epub ahead of print]

PMID:
30169740
9.

Inequalities in HAART uptake and differential survival according to exposure category in Rio de Janeiro, Brazil.

Lima TA, Beyrer C, Golub JE, Mota JCD, Malta MS, Silva CMFPD, Bastos FI.

Cad Saude Publica. 2018 Aug 20;34(8):e00009617. doi: 10.1590/0102-311X00009617.

10.

Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment.

Alfarisi O, Mave V, Gaikwad S, Sahasrabudhe T, Ramachandran G, Kumar H, Gupte N, Kulkarni V, Deshmukh S, Atre S, Raskar S, Lokhande R, Barthwal M, Kakrani A, Chon S, Gupta A, Golub JE, Dooley KE.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01383-18. doi: 10.1128/AAC.01383-18. Print 2018 Nov.

11.

Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India.

Gupte AN, Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte N, Gupta A, Golub JE.

Int J Tuberc Lung Dis. 2018 Jul 1;22(7):800-806. doi: 10.5588/ijtld.18.0026.

12.

Prevalence and Correlates of Snuff Use, and its Association With Tuberculosis, Among Women Living With HIV in South Africa.

Elf JL, Variava E, Chon S, Lebina L, Motlhaoleng K, Gupte N, Niaura R, Abrams D, Martinson N, Golub JE.

Nicotine Tob Res. 2019 Jul 17;21(8):1087-1092. doi: 10.1093/ntr/nty137.

13.

A systematic review of the effectiveness of smoking cessation interventions among patients with tuberculosis.

Whitehouse E, Lai J, Golub JE, Farley JE.

Public Health Action. 2018 Jun 21;8(2):37-49. doi: 10.5588/pha.18.0006. Review.

14.

Sources of household air pollution and their association with fine particulate matter in low-income urban homes in India.

Elf JL, Kinikar A, Khadse S, Mave V, Suryavanshi N, Gupte N, Kulkarni V, Patekar S, Raichur P, Breysse PN, Gupta A, Golub JE.

J Expo Sci Environ Epidemiol. 2018 Jun;28(4):400-410. doi: 10.1038/s41370-018-0024-2. Epub 2018 May 23.

15.

Transmission of Mycobacterium tuberculosis From Patients Who Are Nucleic Acid Amplification Test Negative.

Xie YL, Cronin WA, Proschan M, Oatis R, Cohn S, Curry SR, Golub JE, Barry CE 3rd, Dorman SE.

Clin Infect Dis. 2018 Nov 13;67(11):1653-1659. doi: 10.1093/cid/ciy365.

PMID:
29697779
16.

Relevance and acceptability of using the Quantiferon gold test (QGIT) to screen CD4 blood draws for latent TB infection among PLHIV in South Africa: formative qualitative research findings from the TEKO trial.

Kerrigan D, Tudor C, Motlhaoleng K, Lebina L, Qomfu C, Variava E, Chon S, Martinson N, Golub JE.

BMC Health Serv Res. 2018 Apr 16;18(1):288. doi: 10.1186/s12913-018-3088-8.

17.

Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities.

Beavers SF, Pascopella L, Davidow AL, Mangan JM, Hirsch-Moverman YR, Golub JE, Blumberg HM, Webb RM, Royce RA, Buskin SE, Leonard MK, Weinfurter PC, Belknap RW, Hughes SE, Warkentin JV, Welbel SF, Miller TL, Kundipati SR, Lauzardo M, Barry PM, Katz DJ, Garrett DO, Graviss EA, Flood JM; Tuberculosis Epidemiologic Studies Consortium.

Ann Am Thorac Soc. 2018 Feb 28. doi: 10.1513/AnnalsATS.201705-405OC. [Epub ahead of print]

PMID:
29490150
18.

Risk factors associated with cluster size of Mycobacterium tuberculosis (Mtb) of different RFLP lineages in Brazil.

Peres RL, Vinhas SA, Ribeiro FKC, Palaci M, do Prado TN, Reis-Santos B, Zandonade E, Suffys PN, Golub JE, Riley LW, Maciel EL.

BMC Infect Dis. 2018 Feb 8;18(1):71. doi: 10.1186/s12879-018-2969-0.

19.

Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment.

Degner NR, Wang JY, Golub JE, Karakousis PC.

Clin Infect Dis. 2018 Jan 6;66(2):198-205. doi: 10.1093/cid/cix819.

20.

Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India.

Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte A, Gupta A, Gupte N, Golub JE.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):1280-1287. doi: 10.5588/ijtld.17.0474.

21.

The significance of cytomegalovirus in children with pneumonia admitted for mechanical ventilation.

Gupte AN, Mave V, Meshram S, Lokhande R, Kadam D, Dharmshale S, Bharadwaj R, Kagal A, Pradhan N, Deshmukh S, Atre S, Sahasrabudhe T, Barthwal M, Meshram S, Kakrani A, Kulkarni V, Raskar S, Suryavanshi N, Shivakoti R, Chon S, Selvin E, Gupte N, Gupta A, Golub JE.

Int J Tuberc Lung Dis. 2017 Dec 1;21(12):800-806. doi: 10.5588/ijtld.17.0026.

PMID:
29297442
22.

Secondhand Smoke Exposure and Validity of Self-Report in Low-Income Women and Children in India.

Elf JL, Kinikar A, Khadse S, Mave V, Gupte N, Kulkarni V, Patekar S, Raichur P, Cohen J, Breysse PN, Gupta A, Golub JE.

Pediatrics. 2018 Jan;141(Suppl 1):S118-S129. doi: 10.1542/peds.2017-1026O.

23.

Indoor air pollution from secondhand tobacco smoke, solid fuels, and kerosene in homes with active tuberculosis disease in South Africa.

Elf JL, Eke O, Rakgokong M, Variava E, Baliram Y, Motlhaoleng K, Lebina L, Shapiro AE, Breysse PN, Golub JE, Martinson N.

BMC Res Notes. 2017 Nov 13;10(1):591. doi: 10.1186/s13104-017-2892-2.

24.

Is it time for Brazil to prioritize TB preventive therapy for all people living with HIV?

Maciel EL, Prado TND, Andrade KB, Golub JE.

Braz J Infect Dis. 2018 Jan - Feb;22(1):74-75. doi: 10.1016/j.bjid.2017.10.001. Epub 2017 Nov 6. No abstract available.

25.

Prevalence and Correlates of Smoking Among People Living With HIV in South Africa.

Elf JL, Variava E, Chon S, Lebina L, Motlhaoleng K, Gupte N, Niaura R, Abrams D, Golub JE, Martinson N.

Nicotine Tob Res. 2018 Aug 14;20(9):1124-1131. doi: 10.1093/ntr/ntx145.

26.

Preventing tuberculosis in people with HIV-no more excuses.

Chaisson RE, Golub JE.

Lancet Glob Health. 2017 Nov;5(11):e1048-e1049. doi: 10.1016/S2214-109X(17)30390-X. No abstract available.

27.

Applying the Care Group model to tuberculosis control: findings from a community-based project in Mozambique.

Brown A, Ernst P, Cambule A, Morrow M, Dortzbach D, Golub JE, Perry HB.

Int J Tuberc Lung Dis. 2017 Oct 1;21(10):1086-1093. doi: 10.5588/ijtld.17.0179.

PMID:
28911350
28.

Qualitative Exploration of a Smoking Cessation Trial for People Living With HIV in South Africa.

Krishnan N, Gittelsohn J, Ross A, Elf J, Chon S, Niaura R, Martinson N, Golub JE.

Nicotine Tob Res. 2018 Aug 14;20(9):1117-1123. doi: 10.1093/ntr/ntx139.

29.

Tuberculosis screening among persons with diabetes mellitus in Pune, India.

Mave V, Nimkar S, Prasad H, Kadam D, Meshram S, Lokhande R, Gupte N, Jain D, Gupta A, Golub JE.

BMC Infect Dis. 2017 Jun 2;17(1):388. doi: 10.1186/s12879-017-2483-9.

30.

Prevalence of Kaposi's sarcoma in patients with AIDS and associated factors, São Paulo-SP, Brazil, 2003-2010.

Tancredi MV, Pinto VM, Silva MHD, Pimentel SR, Silva TSBD, Ito SMA, Golub JE, Toscano ALCC.

Epidemiol Serv Saude. 2017 Apr-Jun;26(2):379-387. doi: 10.5123/S1679-49742017000200015. English, Portuguese.

31.

Clinical and epidemiological characteristics associated with unfavorable tuberculosis treatment outcomes in TB-HIV co-infected patients in Brazil: a hierarchical polytomous analysis.

Prado TN, Rajan JV, Miranda AE, Dias ED, Cosme LB, Possuelo LG, Sanchez MN, Golub JE, Riley LW, Maciel EL.

Braz J Infect Dis. 2017 Mar - Apr;21(2):162-170. doi: 10.1016/j.bjid.2016.11.006. Epub 2016 Dec 6.

32.

Tobacco Smoking and Tuberculosis among Men Living with HIV in Johannesburg, South Africa: A Case-Control Study.

Bronner Murrison L, Martinson N, Moloney RM, Msandiwa R, Mashabela M, Samet JM, Golub JE.

PLoS One. 2016 Nov 28;11(11):e0167133. doi: 10.1371/journal.pone.0167133. eCollection 2016.

33.

Risk factors for transmission of tuberculosis among United States-born African Americans and Whites.

Pagaoa MA, Royce RA, Chen MP, Golub JE, Davidow AL, Hirsch-Moverman Y, Marks SM, Teeter LD, Thickstun PM, Katz DJ; Tuberculosis Epidemiologic Studies Consortium.

Int J Tuberc Lung Dis. 2015 Dec;19(12):1485-92. doi: 10.5588/ijtld.14.0965.

34.

Directly observed therapy of tuberculosis in Brazil: associated determinants and impact on treatment outcome.

Reis-Santos B, Pellacani-Posses I, Macedo LR, Golub JE, Riley LW, Maciel EL.

Int J Tuberc Lung Dis. 2015 Oct;19(10):1188-93. doi: 10.5588/ijtld.14.0776.

PMID:
26459531
35.

Tobacco smoking and tuberculosis treatment outcomes: a prospective cohort study in Georgia.

Gegia M, Magee MJ, Kempker RR, Kalandadze I, Chakhaia T, Golub JE, Blumberg HM.

Bull World Health Organ. 2015 Jun 1;93(6):390-9. doi: 10.2471/BLT.14.147439. Epub 2015 Mar 30.

36.

Postarrival Tuberculosis Screening of High-Risk Immigrants at a Local Health Department.

Nuzzo JB, Golub JE, Chaulk P, Shah M.

Am J Public Health. 2015 Jul;105(7):1432-8. doi: 10.2105/AJPH.2014.302287. Epub 2015 Jan 20.

37.

Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study.

Azadi M, Bishai DM, Dowdy DW, Moulton LH, Cavalcante S, Saraceni V, Pacheco AG, Cohn S, Chaisson RE, Durovni B, Golub JE.

Int J Tuberc Lung Dis. 2014 Dec;18(12):1443-8. doi: 10.5588/ijtld.14.0108.

38.

Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.

Golub JE, Cohn S, Saraceni V, Cavalcante SC, Pacheco AG, Moulton LH, Durovni B, Chaisson RE.

Clin Infect Dis. 2015 Feb 15;60(4):639-45. doi: 10.1093/cid/ciu849. Epub 2014 Nov 2.

39.
40.

Active case finding of tuberculosis (TB) in an emergency room in a region with high prevalence of TB in Brazil.

Silva DR, Müller AM, Tomasini Kda S, Dalcin Pde T, Golub JE, Conde MB.

PLoS One. 2014 Sep 11;9(9):e107576. doi: 10.1371/journal.pone.0107576. eCollection 2014.

41.

Reply to "at the crossroads between early or delayed antiretroviral therapy initiation during TB/HIV coinfection".

Saraceni V, Durovni B, Pacheco AG, Chaisson RE, Golub JE.

Braz J Infect Dis. 2014 Sep-Oct;18(5):578-9. doi: 10.1016/j.bjid.2014.07.001. Epub 2014 Aug 7. No abstract available.

42.

Factors associated with tuberculosis by HIV status in the Brazilian national surveillance system: a cross sectional study.

do Prado TN, Miranda AE, de Souza FM, Dias Edos S, Sousa LK, Arakaki-Sanchez D, Sanchez MN, Golub JE, Maciel EL.

BMC Infect Dis. 2014 Jul 28;14:415. doi: 10.1186/1471-2334-14-415.

43.

Prevalent tuberculosis at HIV diagnosis in Rio de Janeiro, Brazil: the TB/HIV in Rio (THRio) Cohort.

Saraceni V, Cohn S, Cavalcante SC, Pacheco AG, Moulton LH, Chaisson RE, Durovni B, Golub JE.

J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):98-101. doi: 10.1097/QAI.0000000000000247.

44.

Impact of isoniazid preventive therapy for HIV-infected adults in Rio de Janeiro, Brazil: an epidemiological model.

Dowdy DW, Golub JE, Saraceni V, Moulton LH, Cavalcante SC, Cohn S, Pacheco AG, Chaisson RE, Durovni B.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):552-8. doi: 10.1097/QAI.0000000000000219.

45.

A comparative assessment of the price, brands and pack characteristics of illicitly traded cigarettes in five cities and towns in South Africa.

Wherry AE, McCray CA, Adedeji-Fajobi TI, Sibiya X, Ucko P, Lebina L, Golub JE, Cohen JE, Martinson NA.

BMJ Open. 2014 May 8;4(5):e004562. doi: 10.1136/bmjopen-2013-004562.

46.

Survival of HIV patients with tuberculosis started on simultaneous or deferred HAART in the THRio cohort, Rio de Janeiro, Brazil.

Saraceni V, Durovni B, Cavalcante SC, Cohn S, Pacheco AG, Moulton LH, Chaisson RE, Golub JE.

Braz J Infect Dis. 2014 Sep-Oct;18(5):491-5. doi: 10.1016/j.bjid.2014.02.004. Epub 2014 Apr 27.

47.

Tuberculosis control in a socially vulnerable area: a community intervention beyond DOT in a Brazilian favela.

Soares EC, Vollmer WM, Cavalcante SC, Pacheco AG, Saraceni V, Silva JS, Neves GR, Golub JE, Efron AR, Durovni B, Chaisson RE.

Int J Tuberc Lung Dis. 2013 Dec;17(12):1581-6. doi: 10.5588/ijtld.13.0152.

PMID:
24200272
48.

Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease.

Hourigan SK, Chirumamilla SR, Ross T, Golub JE, Rabizadeh S, Saeed SA, Elson CO, Kelly CP, Carroll KC, Oliva-Hemker M, Sears C.

Inflamm Bowel Dis. 2013 Dec;19(13):2744-52. doi: 10.1097/01.MIB.0000435434.53871.36.

PMID:
24145927
49.

AIDS-related Kaposi's sarcoma in Brazil: trends and geopolitical distribution.

Saraceni V, Talhari CC, Pereira GF, Golub JE, Talhari S, Miranda AE.

Int J Dermatol. 2013 Dec;52(12):1525-9. doi: 10.1111/ijd.12116. Epub 2013 Oct 18.

PMID:
24134514
50.

From Fort Lee to Phnom Penh: a journey of self-discovery.

Golub JE, Diament-Golub J.

J N J Dent Assoc. 2013 Spring;84(2):24-5. No abstract available.

PMID:
23991504

Supplemental Content

Loading ...
Support Center